ACCESSION: MSBNK-SMB_Measured-HSA031P0135000
RECORD_TITLE: Uncharacterized; LC-ESI-QTOF; MS2; NEGATIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.24, Processed 2025.02.24, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Yu et al. Front Cell Infect Microbiol. 2022,11,763507
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS3233
COMMENT: DATASET_TITLE The gut microbiome and metabolites are altered and interrelated in patients with rheumatoid arthritis
COMMENT: DATASET_AUTHORS Die Yu, Juping Du, Xia Pu, Liyuan Zheng, Shuaishuai Chen, Na Wang, Jun Li, Shiyong Chen, Shaobiao Pan, Bo Shen
COMMENT: MS1_M/Z_AVERAGED_THRES 10.000
COMMENT: MS2_M/Z_AVERAGED_THRES 15.000
COMMENT: DATASET_FILE_NUM 59
COMMENT: NUM_AVERAGED_SPEC 40
COMMENT: RAW_SPEC {'HC10-neg_854': {'bp': 2044.0, 'sum': 3871.0}, 'HC24-neg_823': {'bp': 1853.0, 'sum': 3956.0}, 'RA22-neg_763': {'bp': 1607.0, 'sum': 4172.0}, 'RA23-neg_826': {'bp': 1533.0, 'sum': 3796.0}, 'RA10-neg_833': {'bp': 1490.0, 'sum': 3693.0}, 'RA24-neg_819': {'bp': 1434.0, 'sum': 3095.0}, 'HC4-neg_877': {'bp': 1335.0, 'sum': 2986.0}, 'HC11-neg_841': {'bp': 1306.0, 'sum': 4163.0}, 'HC5-neg_843': {'bp': 1301.0, 'sum': 3594.0}, 'RA19-neg_903': {'bp': 1158.0, 'sum': 2592.0}, 'HC17-neg_813': {'bp': 1146.0, 'sum': 4096.0}, 'QC1-neg_746': {'bp': 1121.0, 'sum': 3245.0}, 'RA3-neg_782': {'bp': 1090.0, 'sum': 2503.0}, 'QC1-neg_741': {'bp': 1050.0, 'sum': 2720.0}, 'RA13-neg_815': {'bp': 1031.0, 'sum': 2424.0}, 'RA8-neg_790': {'bp': 981.0, 'sum': 3215.0}, 'HC21-neg_830': {'bp': 961.0, 'sum': 2720.0}, 'HC2-neg_808': {'bp': 883.0, 'sum': 2147.0}, 'QC2-neg_766': {'bp': 835.0, 'sum': 2255.0}, 'QC3-neg_777': {'bp': 809.0, 'sum': 2592.0}, 'HC8-neg_826': {'bp': 698.0, 'sum': 1470.0}, 'RA6-neg_781': {'bp': 679.0, 'sum': 1756.0}, 'QC2-neg_755': {'bp': 656.0, 'sum': 1500.0}, 'RA23-neg_838': {'bp': 648.0, 'sum': 1676.0}, 'QC6-neg_846': {'bp': 639.0, 'sum': 1534.0}, 'RA7-neg_778': {'bp': 605.0, 'sum': 1360.0}, 'RA12-neg_900': {'bp': 599.0, 'sum': 1318.0}, 'HC25-neg_854': {'bp': 520.0, 'sum': 1266.0}, 'HC18-neg_863': {'bp': 510.0, 'sum': 1222.0}, 'HC3-neg_906': {'bp': 474.0, 'sum': 881.0}, 'QC3-neg_775': {'bp': 430.0, 'sum': 1367.0}, 'HC20-neg_842': {'bp': 402.0, 'sum': 810.0}, 'HC23-neg_786': {'bp': 383.0, 'sum': 841.0}, 'QC8-neg_816': {'bp': 364.0, 'sum': 946.0}, 'RA18-neg_853': {'bp': 355.0, 'sum': 983.0}, 'HC22-neg_852': {'bp': 354.0, 'sum': 991.0}, 'HC23-neg_860': {'bp': 259.0, 'sum': 612.0}, 'QC5-neg_810': {'bp': 254.0, 'sum': 560.0}, 'RA15-neg_892': {'bp': 244.0, 'sum': 672.0}, 'RA10-neg_520': {'bp': 203.0, 'sum': 458.0}}
COMMENT: RETENTION_TIME_STDEV 0.076
COMMENT: PRECURSOR_M/Z_RAW 135.031826
COMMENT: PRECURSOR_M/Z_STDEV 0.000339
COMMENT: PRECURSOR_IN_MS1 mz 135.031201; int 999.000; delta(ppm) -7.752096
COMMENT: PROPOSED_CHARGE_STATE -1; mz 136.033521; int 40.453; cor 0.980
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.279; C5H4N4O; [M-H]1; delta(ppm) -0.279333
COMMENT: PROPOSED_MF SevenGoldenRules 9.556; C4H8O5; [M-H]1; delta(ppm) 9.556120
COMMENT: PROPOSED_MF MS-FINDER 4.819; C5H4N4O; [M-H]-; delta(ppm) -0.276583
COMMENT: PROPOSED_MF MS-FINDER 3.163; C4H8O5; [M-H]-; delta(ppm) 9.627992
COMMENT: PROPOSED_MF MS-FINDER 2.988; C5H12S2; [M-H]-; delta(ppm) 3.192229
COMMENT: PROPOSED_MF SIRIUS5_Sirius 21.479; C5H4N4O; [M-H]-; delta(ppm) -0.276583
COMMENT: PROPOSED_MF SIRIUS5_Sirius 4.326; C4H8O5; [M-H]-; delta(ppm) 9.627992
COMMENT: PROPOSED_MF SIRIUS5_Sirius -0.798; C5H12S2; [M-H]-; delta(ppm) 3.192229
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C5H4N4O; [M-H]-; delta(ppm) -0.276583
COMMENT: PROPOSED_MF SIRIUS6_Sirius 29.064; C5H4N4O; [M-H]-; delta(ppm) -0.276583
COMMENT: PROPOSED_MF SIRIUS6_Sirius 25.105; C3H9N2O2P; [M-H]-; delta(ppm) -12.508908
COMMENT: PROPOSED_MF SIRIUS6_Sirius 17.272; C2H5FN4O2; [M-H]-; delta(ppm) -8.738654
COMMENT: PROPOSED_MF SIRIUS6_Sirius 16.009; C7H6NO2; [M-H]-; delta(ppm) -10.219837
COMMENT: PROPOSED_MF SIRIUS6_Sirius 12.317; C4H9ClN2O; [M-H]-; delta(ppm) -150923.756444
COMMENT: PROPOSED_MF SIRIUS6_Sirius 5.326; C4H8O5; [M-H]-; delta(ppm) 9.627992
COMMENT: PROPOSED_MF SIRIUS6_Sirius 1.127; CH7N5OP; [M-H]-; delta(ppm) -2.565700
COMMENT: PROPOSED_MF SIRIUS6_Sirius 0.202; C5H12S2; [M-H]-; delta(ppm) 3.192229
COMMENT: PROPOSED_MF SIRIUS6_Sirius -3.324; C5H5F3N; [M-H]-; delta(ppm) 7.889091
COMMENT: PROPOSED_MF SIRIUS6_Sirius -3.507; C2H7ClN5; [M-H]-; delta(ppm) -150916.587914
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C5H4N4O; [M-H]-; delta(ppm) -0.276583
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 15.000; OFCNXPDARWKPPY-UHFFFAOYSA-N; C5H4N4O; Massbank:EQ333655 Allopurinol1,2-dihydropyrazolo[3,4-d]pyrimidin-4-one
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 2.000; FDGQSTZJBFJUBT-UHFFFAOYSA-N; C5H4N4O; hypoxanthine
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.364; ONMSHVSDDXZRPS-UHFFFAOYSA-N; [M-H]-; OC=1N=CC2=NCN=C2N1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.278; FDGQSTZJBFJUBT-UHFFFAOYSA-N; [M-H]-; OC1=NC=NC2=C1NC=N2
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.089; AXEBUIBRUVSSHM-UHFFFAOYSA-N; [M-H]-; NC1=C(N=CN1C=O)C#N
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.030; CRIZPXKICGBNKG-UHFFFAOYSA-N; [M-H]-; OC1=NC=C2N=CN=C2N1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.000; OFCNXPDARWKPPY-UHFFFAOYSA-N; [M-H]-; O=C1N=CN=C2NNC=C12
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 8.575; FDGQSTZJBFJUBT-UHFFFAOYSA-N; [M-H]-; Hypoxanthine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 8.091; OFCNXPDARWKPPY-UHFFFAOYSA-N; [M-H]-; Allopurinol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.692; CRIZPXKICGBNKG-UHFFFAOYSA-N; [M-H]-; 2-hydroxypurine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.656; AXEBUIBRUVSSHM-UHFFFAOYSA-N; [M-H]-; 5-amino-1-formylimidazole-4-carbonitrile
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.597; ONMSHVSDDXZRPS-UHFFFAOYSA-N; [M-H]-; CNP0440561
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.581; YPDSIEMYVQERLJ-UHFFFAOYSA-N; [M-H]-; 7,9-dihydropurin-8-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.561; OGCXIHWGXUQTCQ-UHFFFAOYSA-N; [M-H]-; 3H-pyrazolo[4,3-d]pyrimidin-7-ol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.530; NYNNJBKGLLSTAZ-UHFFFAOYSA-N; [M-H]-; CNP0439982
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.528; VHJRRKBEQDXLHP-UHFFFAOYSA-N; [M-H]-; 9-hydroxypurine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.454; JFZSDNLQDTYVEE-UHFFFAOYSA-N; [M-H]-; 1,4-dihydropyrazolo[4,3-d]pyrimidin-7-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.534; FPIRBHDGWMWJEP-UHFFFAOYSA-N; [M-H]-; 3H-[1,2,3]triazolo[4,5-b]pyridin-3-ol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.701; JPIJQSOTBSSVTP-MZTXYVAJNA-N; [M-H]-; Erythronic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.089; PUUCPZKSTXFGOC-UHFFFAOYSA-N; [M-H]-; Ethyl isopropyl disulfide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.089; SNGRPWPVGSSZGV-UHFFFAOYSA-N; [M-H]-; Ethyl propyl disulfide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.071; DPLYGYOSWLFGGY-UHFFFAOYSA-N; [M-H]-; 1-Pentanesulfenothioic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.037; QTWVOHZEDPQFTP-MLHKIVSYNA-N; [M-H]-; UNPD3575
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.993; IASCKZVQSNCRPV-UHFFFAOYSA-N; [M-H]-; 2,2,4-trihydroxybutanoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.967; BBYNYNMPOUQKKS-UHFFFAOYSA-N; [M-H]-; 2,2-Bis(methylthio)propane
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.957; FHEQBJDIKIFJTB-UHFFFAOYSA-N; [M-H]-; 3-hydroxy-3-(methylperoxy)propanoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.915; KMTUBAIXCBHPIZ-UHFFFAOYSA-N; [M-H]-; pentane-1,5-dithiol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; ONMSHVSDDXZRPS-UHFFFAOYSA-N; [M-H]-; CNP0440561
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.958; JFZSDNLQDTYVEE-UHFFFAOYSA-N; [M-H]-; 1,4-dihydropyrazolo[4,3-d]pyrimidin-7-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.882; AXEBUIBRUVSSHM-UHFFFAOYSA-N; [M-H]-; 5-amino-1-formylimidazole-4-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.747; OGCXIHWGXUQTCQ-UHFFFAOYSA-N; [M-H]-; 3H-pyrazolo[4,3-d]pyrimidin-7-ol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.746; OFCNXPDARWKPPY-UHFFFAOYSA-N; [M-H]-; Allopurinol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.744; CRIZPXKICGBNKG-UHFFFAOYSA-N; [M-H]-; 2-hydroxypurine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.738; FDGQSTZJBFJUBT-UHFFFAOYSA-N; [M-H]-; Hypoxanthine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.727; NYNNJBKGLLSTAZ-UHFFFAOYSA-N; [M-H]-; CNP0439982
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.718; YPDSIEMYVQERLJ-UHFFFAOYSA-N; [M-H]-; 7,9-dihydropurin-8-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.695; FPIRBHDGWMWJEP-UHFFFAOYSA-N; [M-H]-; 3H-[1,2,3]triazolo[4,5-b]pyridin-3-ol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.628; VHJRRKBEQDXLHP-UHFFFAOYSA-N; [M-H]-; 9-hydroxypurine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; JPIJQSOTBSSVTP-MZTXYVAJNA-N; [M-H]-; Erythronic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; IASCKZVQSNCRPV-UHFFFAOYSA-N; [M-H]-; 2,2,4-trihydroxybutanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; FHEQBJDIKIFJTB-UHFFFAOYSA-N; [M-H]-; 3-hydroxy-3-(methylperoxy)propanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.634; OFCNXPDARWKPPY-UHFFFAOYSA-N; [M-H]-; 1,5-dihydropyrazolo[3,4-d]pyrimidin-4-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.000; JPIJQSOTBSSVTP-STHAYSLISA-N; [M-H]-; (2R,3S)-2,3,4-trihydroxybutanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.157; FDGQSTZJBFJUBT-UHFFFAOYSA-N; [M-H]-; 1,7-dihydropurin-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.532; FPIRBHDGWMWJEP-UHFFFAOYSA-N; [M-H]-; 3-hydroxytriazolo[4,5-b]pyridine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.126; QBKYWNHLILCGEI-UHFFFAOYSA-N; [M-H]-; 4-cyano-1H-imidazole-5-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.017; DHQDPICNDWFEBQ-UHFFFAOYSA-N; [M-H]-; 5H-pyrazolo[1,5-d][1,2,4]triazin-4-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.947; JFZSDNLQDTYVEE-UHFFFAOYSA-N; [M-H]-; 1,6-dihydropyrazolo[4,3-d]pyrimidin-7-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.918; QICFIUZWDPJRQF-UHFFFAOYSA-N; [M-H]-; 1,6-dihydropyrazolo[3,4-d]pyridazin-7-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.891; CRIZPXKICGBNKG-UHFFFAOYSA-N; [M-H]-; 3,7-dihydropurin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.874; GXBDCPYXMVITMR-UHFFFAOYSA-N; [M-H]-; 1H-[1,2,4]triazolo[1,5-a]pyrimidin-7-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.873; YPDSIEMYVQERLJ-UHFFFAOYSA-N; [M-H]-; 7,9-dihydropurin-8-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.866; QMFPURRPZZSJPF-UHFFFAOYSA-N; [M-H]-; 3H-imidazo[2,1-f][1,2,4]triazin-4-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.862; GLVYFVYELPFNQC-UHFFFAOYSA-N; [M-H]-; 6H-pyrazolo[5,1-c][1,2,4]triazin-4-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.826; RDHMBEKEDDDWOF-UHFFFAOYSA-N; [M-H]-; 4H-[1,2,4]triazolo[1,5-a]pyrimidin-5-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.795; RBWFEMOYMLQPAV-UHFFFAOYSA-N; [M-H]-; 1,5-dihydropyrazolo[3,4-d]pyridazin-4-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.793; DSZCQHJBMSIMNX-UHFFFAOYSA-N; [M-H]-; 3,6-dihydroimidazo[4,5-d]pyridazin-7-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.778; CLGWVBPVZYVPMR-UHFFFAOYSA-N; [M-H]-; 2H-[1,2,4]triazolo[4,3-a]pyrazin-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.754; JDPCCIANHKTFII-UHFFFAOYSA-N; [M-H]-; 6H-[1,2,4]triazolo[1,5-c]pyrimidin-5-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.753; VNMKCHFGAZFWKI-UHFFFAOYSA-N; [M-H]-; 6H-[1,2,4]triazolo[4,3-c]pyrimidin-5-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.725; GJDZQWVZICYPIT-UHFFFAOYSA-N; [M-H]-; [1,3]oxazolo[5,4-d]pyrimidin-7-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.702; REINGZOTPYBONL-UHFFFAOYSA-N; [M-H]-; [1,2]oxazolo[5,4-d]pyrimidin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.660; WKOSBXIJGCIJII-UHFFFAOYSA-N; [M-H]-; [1,2]oxazolo[4,5-b]pyrazin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.185; LGSBQUSNSQFXGC-UHFFFAOYSA-N; [M-H]-; 2-hydroxy-2-(2-hydroxyethoxy)acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.175; ZQBWCQHCMJERPW-UHFFFAOYSA-N; [M-H]-; 2-(1,2-dihydroxyethoxy)acetic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -30.094; FDGQSTZJBFJUBT; [M-H]-; Sarcine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -63.643; CRIZPXKICGBNKG; [M-H]-; 2-Purinol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -90.436; YPDSIEMYVQERLJ; [M-H]-; 7H-Purin-8-ol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -92.937; OFCNXPDARWKPPY; [M-H]-; Ailurial
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -97.919; JFZSDNLQDTYVEE; [M-H]-; Zyloprim (TN)
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -117.877; JDPCCIANHKTFII; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -120.291; GXBDCPYXMVITMR; [M-H]-; [1,2,4]Triazolo[1,5-a]pyrimidin-7-ol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -126.946; NYNNJBKGLLSTAZ; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -155.125; DHQDPICNDWFEBQ; [M-H]-; AmbscX-046497
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -161.098; FPIRBHDGWMWJEP; [M-H]-; 1-Hydroxy-7-azabenzotriazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -163.216; CYYQSLSRZGVVHE; [M-H]-; Purine 3-oxide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -205.735; QBKYWNHLILCGEI; [M-H]-; ACMC-20amkb
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -206.977; AXEBUIBRUVSSHM; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -213.211; OGCXIHWGXUQTCQ; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.419; FDGQSTZJBFJUBT; [M-H]-; Sarcine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -23.513; FDGQSTZJBFJUBT; [M-H]-; Sarkin
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -55.939; CRIZPXKICGBNKG; [M-H]-; 7H-purin-2-ol
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -73.096; JFZSDNLQDTYVEE; [M-H]-; 7-Hydroxypyrazolo[4,3-d]pyrimidine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -79.528; JDPCCIANHKTFII; [M-H]-; 6H-[1,2,4]Triazolo[1,5-c]pyrimidin-5-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -79.812; OFCNXPDARWKPPY; [M-H]-; 2H-pyrazolo[3,4-d]pyrimidin-4-ol
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -81.581; YPDSIEMYVQERLJ; [M-H]-; 7H-Purin-8-ol
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -82.717; NYNNJBKGLLSTAZ; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -98.574; RBWFEMOYMLQPAV; [M-H]-; 1,5-Dihydropyrazolo[3,4-d]pyridazin-2-ium-4-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -103.082; ONMSHVSDDXZRPS; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -103.368; QICFIUZWDPJRQF; [M-H]-; 1,6-Dihydropyrazolo[3,4-d]pyridazin-2-ium-7-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.127; FDGQSTZJBFJUBT; [M-H]-; Sarkin
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C5H3N4O1; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1), SIRIUS5_Sirius(1), SIRIUS5_Zodiac(1);
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Feces
AC$INSTRUMENT: UPLC system, AB SCIEX - TripleTOF 5600+ mass spectrometer, AB SCIEX
AC$INSTRUMENT_TYPE: LC-ESI-QTOF
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE NEGATIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY -30 V
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE -4.5 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 10.00; MS2(ppm) 15.00
AC$CHROMATOGRAPHY: COLUMN_NAME ACQUITY UPLC T3 column (1.8 Âµm, 100 mm x 2.1 mm; Waters)
AC$CHROMATOGRAPHY: FLOW_GRADIENT 0.0-0.5 min, 5% B; 0.5-7.0 min, 100% B; 7.0-8.0 min, 100% B; 8.0-8.1 min, 5% B; 8.1-10.0 min, 5% B. 
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 1.376
MS$FOCUSED_ION: PRECURSOR_M/Z 135.031197
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-00kf-9100000000-0e14648a15ea1c70d089
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  65.0141918 556.6853 65.013855 8.6904 147.03 0.7599 40 f{C3H1N2}/-5.07ppm,p-C2H2N2O1
  66.0094996 280.7782 66.009160 11.5892 105.20 0.6531 40 f{C4H2O1}/-24.45ppm,p-C1H1N4
  92.0253321 999.0000 92.024945 9.8342 0.00 0.7445 40 f{C4H2N3}/-0.96ppm,p-C1H1N1O1
  133.0154839 122.0640 133.015050 14.2465 64.18 0.2332 32 f{C5H1N4O1}/-0.75ppm,p-H2
  135.0306914 147.7400 135.030270 15.2558 73.03 1.0000 37 f{C5H3N4O1}/-4.02ppm,p
PK$NUM_PEAK: 5
PK$PEAK: m/z int. rel.int.
  65.014192 556.69 556
  66.009500 280.78 280
  92.025332 999.00 999
  133.015484 122.06 122
  135.030691 147.74 147
//
